<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

AACR20 Poster 5614: Combination Anti-TIGIT and PD-1 Assessment with Double Knock-In Checkpoint Target Models

Combination immunotherapy has the potential to improve patient response rate to anti-PD-1 agents, overcoming the compensatory immune inhibitory pathways that suppress efficient antitumor responses.